Cantor Fitzgerald Reiterates Overweight Rating for LifeMD (NASDAQ:LFMD)
LifeMD (NASDAQ:LFMD – Get Free Report)‘s stock had its “overweight” rating reissued by equities research analysts at Cantor Fitzgerald in a report issued on Tuesday,Benzinga reports. They presently have a $15.00 price target on the stock. Cantor Fitzgerald’s price target indicates a potential upside of 159.97% from the stock’s current price. Several other research analysts […]
LifeMD (NASDAQ:LFMD – Get Free Report)‘s stock had its “overweight” rating reissued by equities research analysts at Cantor Fitzgerald in a report issued on Tuesday,Benzinga reports. They presently have a $15.00 price target on the stock. Cantor Fitzgerald’s price target indicates a potential upside of 159.97% from the stock’s current price. Several other research analysts […]
